http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23067908

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study
endingPage 86
issn 1532-1827
0007-0920
issueIdentifier 1
pageRange 82-86
publicationName British Journal of Cancer
startingPage 82
bibliographicCitation Cappuzzo F, Bartolini S, Ceresoli GL, Tamberi S, Spreafico A, Lombardo L, Gregorc V, Toschi L, Calandri C, Villa E, Crinò L. Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC). British Journal of Cancer. 2004 Jan 06;90(1):82–6. doi: 10.1038/sj.bjc.6601470.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29aa45f421527d339fe65e152e2bc83a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23b0ccf810b886c946d602dd453d9ebb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85858fe0a1c87ddfbd5393eb1c414252
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9af45e7e0a8891bb6eb6c2ec941019b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07ef4a096c37e86678990f0b1ce7a2a4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b29c010c5381c94ea5c20e3078be2e26
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e57c54225932968b3304c7db810e1ae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ca9cad153c52e32a467bda922432130
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bee4d3e661a025fe01642499597b83c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bab30c03a4f84cc76bccc17701b6c22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1830e0c5924e93e9e756e3b956c60999
date 2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6601470
https://pubmed.ncbi.nlm.nih.gov/PMC2395316
https://pubmed.ncbi.nlm.nih.gov/14710211
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
discusses http://id.nlm.nih.gov/mesh/M0444984
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D011799Q000494
http://id.nlm.nih.gov/mesh/D000375
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011799Q000627
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D002289Q000473
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000970Q000009
http://id.nlm.nih.gov/mesh/D011799Q000009
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D003967Q000139
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008175Q000473
http://id.nlm.nih.gov/mesh/D000077156
http://id.nlm.nih.gov/mesh/D012871Q000139
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6777
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8145
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 71.